Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
ACT-Accelerator We co-convene the diagnostics pillar of this global collaboration to ensure access to COVID-19 tests for everyone, everywhere.
G20 in India We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Diagnostics & IP Find out how intellectual property rights are protected in the diagnostics industry.
Press release FIND and Republic of Indonesia Ministry of Health ink partnership to drive access to essential diagnostic tests
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Press release FIND and VIA Global Health partner to expand access to quality diagnostics in low- and middle-income countries VIA Global Health, FIND 17 May 2023
FIND G20 engagement Diagnostic priorities at the 2023 G20 health working group discussions in India 19 Apr 2023
Press release FIND partners with manufacturers to improve affordability and access to point-of-care HbA1c testing in low- and middle-income countries FIND 24 Mar 2023
